Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Management of acute coronary syndrome wikipedia , lookup
Remote ischemic conditioning wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Electrocardiography wikipedia , lookup
Myocardial infarction wikipedia , lookup
Cardiac surgery wikipedia , lookup
Atrial fibrillation wikipedia , lookup
Heart failure wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
JACC Vol, 19, No. 6 May 1992 :1180-4 1 18 0 Baroreflex Loading Maneuvers Do Not Suppress Increased Plasma Arginine Vasopressin in Patients With Congestive Heart Failure STEVEN R. GOLDSMITH, MD, FACC Minneapolis, Minnesota Nonspecific baroreflex loading maneuvers such as head-down tilt readily suppress Aimulated arginine vasopressin levels in normal tion with mannitol. Mannitol Increased osmolality from 287 ± 9 .2 humans. 8 .2 mOstWkg (p < 0.01) on two occasions. No significant suppresston of arginine vasopressin was seen during head-down tilt after mannitol infusion compared with values in a time control period. These results are consistent with an abnormality in baroreflex suppression of arginine vasopressin secretion in chronic congestive heart failure and suggest that such a defect may contribute to long-term high levels of arginine vasopressin in this condition . (J Am Coll Cardiol 1992 ;19:1180-4) To test the hypothesis that the increased arginine vaso- pressin levels in patients with congestive heart failure would not respond normally to harreflex loading, 12 patients with conger live heart failure had arginine vasopressin levels and osmolality determined in the supine position and after 15 min of 30' head-down tilt. Arginlne vasopressin was increased to 6 .5 t 2.0 pglml at control measurement and did not decrease . Eight patients underwent further study after osmotic stimula- The pathophysiologic process leading to chronically elevated arginine vasopressin levels in congestive heart failure remains poorly understood . Several reports (1-8) have confirmed that arginine vasopressin levels tend to be on average at least twice normal in congestive heart failure, clearly in the range where one would expect hydro-osmotic effects and often in the range associated with vasoconstriction . Discovering the mechanism responsible for producing increased arginine vasopressin levels in congestive heart failure may therefore be of more than academic interest . It is clear that although arginine vasopressin will decrease in response to declining osmolality in congestive heart failure (4-6), plasma levels remain high, suggesting either that there is a nonosmotic drive that "resets" the arginine vasopressin/ osmolality, relation or that there is interference with the renal effects of arginine vasopressin, in effect a state of partial renal diabetes insipidus. Mast speculation to date with regard to nonosmotic drive has focused on baroreflex mechanisms, which, if impaired in congestive heart failure, could lead to increased arginine vasopressin levels by a loss of tonic inhibitory input to the responsible hypothalamic cardiovascular control centers ; however, tonic baroreceptor-mediated restraint of arginine From the Hennepin County Medical Center, Cardiology Division, Minneapolis, Minnesota . This research was supported by a grant-in-aid from the American Heart Association, Dallas, Texas . Dr. Goldsmith is an Established investigator or the American Head Association and the CIBA-Geigy Corporation, Summit, New Jersey . Manuscript received September 4, 1991 ; revised manuscript received Novemhr 5, 1991, accepted November 5. 1991 . Address for repdma: Steven R . Goldsmith, MD, Hennepin County Medical Center, Cardiology nivnioo, 701 Park Avenue, Minneapolis, Minnesole 55415 . 01992 by the American College of Cardiology to 294 ± 7.8 mOsmlkg (p < 0.001) and from 288 2 9 to 299 ± vasopressin secretion is difficult to demonstrate in humans (9-12) . Severe hypotension is required for the nonosmotic release of arginine vasopressin in normal humans (13), and this is not afeature of chronic stable congestive heart failure . However, we and others (14,15) have shown that in normal humans, increased baroreflex activity will suppress arginine vasopressin levels that are already increased by osmotic stimulation. It is therefore possible that impaired baroreceptor function in congestive heart failure could contribute to the maintenance, if not the initial generation, of increased arginine vasopressin levels . This possibility was the focus of the current study, in which the response of plasma arginine vasopressin to head-down tilt was assessed in a group of patients with chronic stable congestive heart failure . Methods Study subjects. Twelve patients with chronic congestive heart failure on the basis of either ischemic (n = 4) or idiopathic (n = 8) cardiomyopathy participated in these investigations . The protocol was reviewed and approved by the Hennepin County Medical Center Institutional Review Board and all patients gave informed consent . There were nine men and three women, and their ages ranged from 43 to 78 years (mean 62) . All had confined severe reduction in left ventricular ejection fraction by angiography . radionuelide study or echocardiographic measurement . All patients but one were receiving therapy with digitalis, diuretic agents and vasodilators, which were withheld at least 12 h before the study . In all cases, vasodilator therapy included an angiotensin-converting enzyme inhibitor. Protocol. The initial investigation proceeded as follows . On reporting to the laboratory after an overnight fast, the 0735-1097152155.00 JACC I . . Iv. No. a May 17:2; 1 180-4 coLDSStrrn RARUREI-LEXES AND VASOPRES5IN IN HEART FAILURE subjects were positioned comfortably in a IO° head-up position on a tilt table . An intravenous cunnula was placed in a vein in an arm or hand to obtain blood samples . Baseline heart rate and arterial pressure were recorded by an automated cuff. A 30-min rest period was then observed . after which control values for heart rate, arterial pressure, plasma arginine vasopressin and plasma osmolality were obtained . The subjects were then placed in a 30' head-down tilt for 15 min, and all measurements were repeated . In five subjects, plasma atrial natriuretic factor levels were also measured before and during the tilt . Eight subjects participated in , e estensi, •r 3-dnv investigation . On I day . subjects were simply observed for 30 min after control measurements were taken and then placed in a 30° head-down tilt position for 15 min . On a 2nd day, after control observations, they received a 250-m1 infusion of a 20% mannitol solution over a 30-min period, after which all measurements were repeated. Although associated with brief intravascular volume expansion, mannitol in this amount has been previously shown to exert a net stimulating effect on plasma arginine vasopress .a levels in patients with congestive heart failure (16) . On this day . they were then observed in the supine position for an additional 15 min . On a 3rd day, after control measurements . subjects received a mannitol infusion identical to that given on the 2nd day . Measurements were repeated at 30 min, and subjects were then placed in a 30" head-down position for 15 min . The eight subjects therefore had a 30-min control period followed by 15 min of head-down tilt on I day, a 30-min infusion of mannitol followed by a 15-min control period on I day, and a 30-min mannitol infusion followed by 15 min of head-down tilt on I day . The order of the 3 days was prospectively randomized . We therefore hoped to test I) whether any response of arginine vasopressin to head-down ti'.*T was reproducible in patients with congestive heart failure . and 2) whether, if a blunted response to basal arginine vasopressin levels to head-down tilt was found in the initial study, additional osmotic stimulation would lead to a greater sensitivity to nonosmotic suppression in analogous fashion to what we had previously shown in normal subjects. Assays. Blood samples were drawn into prechilled tubes, kept on ice and cold centrifuged with the plasma frozen at -4°C for later analysis for plasma arginine vasopressin . Serum was separated for determination of osmolality, which was performed on fresh samples by the freezing-point depression method . Plasma arginine vasopressin was analyzed by a sensitive and specific rrtdioimmunoassay by Dr. Allan Cowley at the Medical Colle,>,e of Wisconsin. Current interand intraassay coefficients of variation average approximately 4%, and the assay reliably detects levels of plasma arginine vasopressin down to 0 .3 pg/ml. Plasma atrial natriuretic factor levels were measured in the Biochemical Core Laboratory at the University of Minnesota by radioimmunoassay . The coefficient of variation is 7% and the normal range is 7 to 40 pg/ml. 1181 Table 1 . Response of htemorfynamic and Plasma variables to Head-Down Tilt in 12 Patients With Congestive Heart Failure Head-Down Coneat HR Ibeakrmlnl MAP no ASP 73 0 12 85!6 .5 Hp ImOsrvkgl 290 V 7 .8 75 - Tia 11 88'_8.8 290 0 ' .2 ASP Ippt'mlt 6.5 *_ 2.0 6 .5 ANF :pFmll' 132_102 120 0 0 98 2 .3 'Measurements in five patients . Values are mean values ± I SD : no changes were statistical!, ;p.ficant . ANF = plasma at dal natriuretic factor: AV P = plasma ar&nine -p-m, HR = heart ram: MAP = mean arrerrl pressure : 0553 = p!a>ma osmolality . Statistics. Data were analyzed as follows . A paired I test compared the control and head-down tilt values for heart rate, arterial pressure, arginine vasopressin, osmolality and atria) natriuretic factor in the subjects studied on one occasion only . For the eight subjects studied on 3 additional days, a multiple-factor analysis of variance compared the responses of heart rate, arterial pressure, arginine vasopressin and osmolality across time on each study day and between study days . Results Initial measurements. Table I shows the responses of heart rate, arterial pressure, arginine vasopressin and osmolality taken in the control period and after 15 min of head-down tilt in all 12 subjects initially investigated . Baseline plasma arginine vasopressin levels were elevated in these patients to 6.5 ± 2.0 pglml (normar 3.5 '_ I pg/mI). As can be seen, there were no significant changes in any variables during tilt . In the five subjects in whom atria) natriuretic factor measurements were also made, there was also no change from the baseline level of 132 ± 46 pg/ml . (normal 22 ± I t peril) Patients studied on 3 different days (Table 2). In the eight patients, there was no significant change in osmolality or arginine vasopressin at any time on the day in which no mannitol was given, confirming reproducibility of the failure to suppress arginine vasopressin in the larger series . Arginine vasopressin and osmolality increased significantly as expected in response to the mannitol infusion, and the responses between the 2 days on which mannitol was given were not different . Osntolality and arginine vasopressin levels tended to decrease slightly 15 min after mannitol infusion on both of the additional study days ; however, the response did not differ between these 2 days, suggesting that head-down tilt had no suppressive effect on the further stimulated arginine vasopressin levels produced by mannitol . Discussion Control ofarpniaevasnprecsinsecretianinhumans. Arginine vasopressin secretion appears to be less sensitive: to baroreflex modulation in humans than in certain experitnen- GOLDSMITH IAROREFLEXES AND VASOPRESSIN IN HEART FAILURE 1 182 Table 2. Results of the 3-Day Study in Eight Patients With Congestive Hean Failure Day I HR (beatsimin) MAP (mm Hg) OSM (mOsmikgl AVP(pgiml) Control I Control 2 Head-Down Till 78 ! I I 82 1 8 .4 288 1 9.3 6 .41-0.96 76 ± 12 87 1 6.3 290'_ 7 .8 6 .511 .2 791 12 91 *_ 7 .7 2901 7 .2 6 .911 .8 Control I Mannitol 75 *- 13 90 *_ 7 .7 288 x 9 6 .5 1 1 .4 80 ± I I 91 t 9.1 299 t 8 .2' 9 1 2,6' Control I Mannilol Day 2 HR (beats/min) MAP (mm Hg) OSM (m0sm11,g) AVP (pg/m) Time Control 79 90 296 7 .9 ! 0 1 1 14 12 8 .4' 1 .7' Day 3 Head-Down Tilt HR (beatslmin) 72 1 14 79 ^- 11 82 1 II MAP (mm Hg) 82 1 7 .5 84 1 7 90 , 6.2 OSM (m0smlkg) 2871 9.2 294'_ 7,8' 293 1 8.2' 6 .5 _ 1 .4 82 t 1 .8' 7 .31 1 .7' AVPIpelmll 'p < 0.01 versus day I. Both osmolality and plasma arginine vasopressin were significantly increased ip < (;.act) after mannitol infusion tMannitull compared wirh control measurements (Control I) on days 2 and 3 and (p < 0.01) eompaed with values on Day I without mannitol infusion . There was no difference between the 2 days on which mannitol was given (days 2 and 3). Head-down fill I, and of plasma arginine vasopressin to 3) 7ompared with the time control did not increase plasma arginine vasopressin on day there was no difference in the response head-down till after mannitol infusion (day on day 2 . The order of the 3 days was prospectively randomized. Abbrevia- tions as in Table 1 . tat animals (17,18) . In the dog, for example, small reductions of central venous or arterial pressure readily increase plasma arginine vasopressin at constant osmolality . In humans, however, severe hypotension is required before arginine vasopressin will be released (12,13) . This observation implies that there is less tonic baroreceptor-mediated restraint of arginine vasopressin release in humans, since only a relatively powerful unloading stimulus will release arginine vasopressin nonosmotically at constant osmolality . On the other hand, we and others (14,15,17-19) have shown that although baroreflex loading maneuvers do not decrease basal arginine vasopressin levels in normal humans, such maneuvers (head-down tilt, head-out immersion) do decrease arginine vasopressin levels if secretion has been stimulated by such means as the administration of a hypertonic saline solution, prior dehydration or the application of thermal stress. These studies. suggest that although there is less tonic baroreflex-related restraint of arginine vasopressin secretion in normal humans, baroreflex loading readily modulates increased hormone levels . The current study was therefore designed to test the hypothesis that baroreceptor-mediated suppression of the increased arginine vasopressin levels in congestive heart sACC Val. 19, No. 6 May 1992 :1180-4 failure might be abnormal. In addition, we further stimulated arginine vasopressin levels c .tth mannitol in an attempt to elicit the latent sensitivity of arginine vasopressin to baroreceptor suppression even if it were not evident in the basal state . The results are consistent with a defect in the hamr . ceptor-related mechanisms responsible for suppressing arginine vasopressin secretion in congestive heart failure, both in the basally increased state and after additional osmotic stimulation . Head-down tilt as a stimulus . Head-down tilt is a nonspecific baroreceptor loading maneuver . We have documented (15,19) that this maneuver is associated with a sustained increase is central venous pressure in normal humans . In addition, although there are usually no direct effects on arterial pressure, the head-down tilt maneuver results in hydrostatic stress on the carotid sinus and therefore must be considered to deliver at least a mild stimulus to the sinoaortic baroreceptor as well. The maneuver readily suppresses sympathetic activity in normal humans (20,21), and we have previously confirmed that although it does not decrease basal arginine vasopressin levels in normal humans (19), head-down tilt readily suppresses arginine vasopressin levels if they are subjected to prior osmotic stimulation (15). These results are analogous to those of von Ameln et al. (14), who resolved the long-standing controversy concerning the response of arginine vasopressin to head-out immersion in normal humans. Head-out immersion, like head-down tilt, is a maneuver that results in an increase in central blood volume and central venous pressures . Von Ameln et al. (14) clearly showed that the application of head-out immersion did not alter basal arginine vasopressin levels in normal humans, but that if levels were stimulated by a combination of dehydration and increased osmolality, immediate suppression of arginine vasopressin during immersion was seen . Taken together, these studies in normal humans suggest that the application of nonspecific baroreceptor loading maneuvers does suppress arginine vasopressin in normal humans if levels are high before the stimulus is applied . We did not measure central hemodynamics in this study . However, it was recently reported (22) that a virtually identical head-down tilt did, as expected, result in an increase in central venous pressures in patients with congeslive heart failure . This increase is not surprising, because patients with congestive heart failure, with abnormal preload reserve, would be expected to have, if anything, a larger response in central venous and pulmonary capillary wedge pressure than normal subjects when placed into a head-down position . Although both pressure and volume measurements would be needed to fully explore the degree of signal given to the cardiac baroreceptors, since they respond ID stretch, it therefore seems that head-down tilt is a stimulus that is capable of "loading" cardiopulmonary and sinoaortic baroreceptors in patients with congestive heart failure as well as in normal persons at least as reflected by pressure and gravitational considerations. We (20) have previously shown that plasma norepinephrine does not respond nor- Vut. 19. Nd. 6 May 1992:11g0-4 JACC G01-11SAHTH BAROREFLEXES AND vasopnESSIN IN HEART FAILURE really to head-down tilt in congestive heart failure . suggesting that there is abnormal baroreflex regulation of the sympathetic nervous system in response to this maneuver . The current results are analogous to those with plasma norepinephrine and suggest that there is also an abnormality in baroreflex suppression of the increased arginine vasopressin levels of congestive heart failure . Possible explanations for the results. It is not possible from these studies to identify the mechanism responsible for the absence of baroreflex suppression of arginine vasopressin in congestive heart failure . Possible explanations for baroreflex failure during head-down tilt include I I less afferent signal from either less relative stretch on the baroreceptors or diminished responsiveness of the baroreceptors themselves, either in the heart or in the sinoaortic area : 2) abnormal central processing of a normal afferent signal : or 1 18 3 Conclusions. We have demonstrated that increased arginine vasopressin levels are not responsive to a baroreflex loading stimulus in congestive heart failure . even after additional osmotic stimulation with mannitol . These data, along with observations on the sympathetic nervous system and atrial natriuretic factor, suggest that abnormal baroreceptor function in congestive heart failure may contribute significantly to the overall imbalance in neuroenducrine activation. In turn, such an imbalance may contribute to the excessive vasoconstriction and salt and water retention characteristic of tuffs disease, although a causal link between abnormalities in these systems and the pathophysiologic processes in congestive heart failure has yet to be firmly established . As with the renin-angiotensin system. long-term pharmacologic manipulation of these systems would be required to provide such proof. 3) deficient efferent response to normal central output . Most experimental data suggest that the abnormality is probably at the level of the haroreceptors themselves . because, at least with regard to sympathetic responses . baroreceptor function W-1, Cam? Crayeu . RN for her help in cardcaheg these studies : Meredith Skelton for the arginine mpres «aye and Tim Ono and Becky Wcs(ergree for preparing the manuscript seems to be restored by heart transplantation (23) and to be improved by pharmacologic treatment such as angiotensinconvening enzyme inhibition 1241 and digitalis (25). which References can indirectly modulate baroreceptor discharge . Whatever the mechanism . the current data suggest that abnormal baroreceptor function may . in part, underlie the long-term elevations of arginine vasopressin in congestive heart failure. However, there is apparently very little tonic restraint GoldsmithSn.FearsisGS.CmwleyAW .LeeinnTB .CahnJN.teoieased plasma erginiee vasopressin levels in patients with congestive head Adore. I A. Coll Capital 1983:11385-90 . ' . RieggerGAO.LielunG .K0chsiekK-Antidiserachormoneincongeslive head failure. Am 1 Med 1902:72:49-52 . 3 . Prchisce J, tensing J, Laragh J . Cody RI. Wekster B. Phlelet and plasma . .-Id hypertension and congestive heart failure. Hy-p-n' pe-mot 5lsuppl 111983:1-129-32. 4 . Pmszczynski W, Vahanian A, Ardaitlou R . Role of antidiuretic hormone in impaired water excretion in patients with congestive heart failure . J Clio Eedocnrml Metab 198458 :599-605. 5. Meuauer B . Roukau IL. Biebet D, e1 at. Sodium and water excretion abnonnalitiesincongutiveheanfailure . Ann Intern Med 1W,105 :161-7- of arginine vasopressin by baroreceptor mechanisms In normal humans (17,10). Defective baroreceptor function is therefore not likely to independently lead to high arginine vasopressin levels in congestive heart failure . Other causes of nonosmotic stimulation of arginine vasopressin would perhaps be more likely to account for the initial elevation of arginine vasopressin in this syndrome . These might include the stimulating effects of Pngiotensin I( or central sympathetic activity or the presence of antagonists to the renal effects of arginine vasopressin, such as prostaglandin E, or atrial natriurtic factor . Once arginine vasopressin was stimulated, however, failure of normal baroreflex suppression could certainly have a permissive effect on the perpetuation of increased arginine vasopressin levels . Atria) natriuretic factor responses . Finally, we measured atrial natriuretic factor levels in 5 of the 12 subjects studied on one occasion . The mean basal levels were 132 ± 102 pg/ml . and there was no increase after head-down tilt . These observations therefore confirm the recent results of Moe et al . (22) that in congestive heart failure, increased atrial natriuretic factor levels may not respond normally to a central volume expansion, which was produced in their study by a head-down tilt similar to that used in our study . These data suggest that atrial natriuretic factor may also be poorly responsive to normal physiologic stimuli in chronic congestive heart failure . This lack of response may deprive patients with this condition of a normal natriuretic mecha- nism useful to counteract central blood volume expansion . I . k Goldsmith SR . Cocky AW . Francis GS. Cohn 1N. ArOnitle vasopressin and the rend response to water loading in congestive heart failure . Am J Candid) 1986:58 :295-9. 7. Gotdmirh 5R. Francis GS. Cowky AW. GaMenberg 1 . Cohn JN. Heeiodynamic eR is of infused arginine vasopressin in congestive heart failure. J Am Coil Cardiol 1986 :8:779-83. 8. Creager MA . Foam DP. Carter SS. Kuhlman 0. Ryan TJ, Gams H. Contribution of vasopressin 1o vasaconudction in patients with tonges- avc heart failure : era nparison with the renin-as gimensie system and the sympathetic nervous system . J Am Coll Cannot 1986 :7:758-65. 9. tiueiz KL. Bond GC . Smith WE. Effect of moderate hemorrhage in humans on plasma ADH and rein . Pme Snc Rep Bid Med 1974:145: 277-80. 10. Goldsmith SR. Francis (is, Cowley AW, Cohn JN . Response of vaso- pressin and nmepemphdm to lower body negative pnasure in hamans . Am J Physiot 1902:272 :H970-3. 11. Goldsmith SR . Cowley AW . Cohn JN . Reflex control of asmndcally slimulded vasopressin in normal man . Am 1 Physial l985:240:R560-3. 12. Goldsmith SR. Dodge D. Cawley AW . The elect of moderate hypoine. sion on arginine vasopressin levels in normal humans . Am J Med Sci 1989'298 :295-8. 13. de Lent IS . Mantilla P . Pan M. et at. Abrupt homeostatic responses to transient ielrnaardiac occlusion during balloon valvuloplasty . Ate 1 Card1o1 1989 :64 :491-7 . 14, van Ameln H, Latin . M. eke, L, Kirsch KA. Effects of dehydralitin on the vasopressin response to immersion . J App) PAysiol 1985 ;58:11420. 15. Goldsmith 5R. Baroreceptormediated suppression of osmotically stimubled vasopressin in normal humans . J AppI Physiol 1988 :65:1226-30. IIR4 GOLDSMITH BAROREFLEXES AND VASOAtSSSIN IN Hr ART FAILIJRE 16. Ilrelsky B, Verbnlis 1 . Generalovich T, Valdes A . Redds PS. Plasma vasapreasin response to osmotic and homodynam'cat nub ~n rongesbse Sean failure. Am J Physiol 1985 :248:11396-402. 17. Goldsmith SR. Bamradex control of vasopressin slerelion in normal hnmxns . In' Cowley AW Jr. ).card I .F . Ausicllo DA . eda. Vnsnpraca a: Cellular and Inlelaalive Fmstions, (Proceedings of the Second Interns. lions) Veaaprcaafn Symposium .) Ncw York : Raw s . 198E:389-97. 18. NorskP.Infaenceoflow-andhigh-pressure barorefeaesaayasopressin release in humans. Acta Endocrinol 1989 ;121 ;7-27. 19. Goldsmith SR, Cowley AW, Fmpas GS, Cohn Jb . LRecls of increased central venous and sonic pressure on plasma vasopressin in Iran . Am I Physiol 1984 :246:11647-51 . 20. Gold-!h SR . Impaired ,,pp-inn of plxsmx n,mpineplvirr, dur'mg handdown till in patients with congestive hear failure . Am Heart J IY91 :172Jim-721 . Goldsmith SR . Hacking Gl. Effect of a presser infusion of enkiolenain II JACC Vol. 19 . No . 6 May I5921Inn_a en sympathetic activity and heart rule in normal humans . Clsc free 1991 AN:261-H^ . Mn, GW. Canepn•A nson CW. A .mal- ._sg VW . Howxrd R. Responu of 09101 narriuretia Met,- : no,mml Change in patiems with heart failure versus subjcas wish normal hemodynamicsd l Am Coll CanIiol 19911;1, 599-606. 23, Glivav MT. Levine TB . Ring WS . St ... A . Calm JN. Nanralieu:ion of sympathetic ncrvan system hmctinn after irthntnpic cardiac Imosplon . lariun in mmr Circoluliun 1987.761suppl VIN-62-4. 24 . CodyRJ .FranklinYW .KIaaaJ.LanghOH .Mechanismsgorernin_erhe pnsmral rcsponsc and harnrcucpror ahnnrmalilies in chronic cougestitt head failure : effects of tictitea id lung4enn converting enevma hlhilitiun . Crrcolatnn 1982:fi6Ii5-42. 25 . Fcrgusnn DW . Abboud FM . Mark AL . Selective impairment of baeore . flex-medialed vasocoastriotor responses in patients with ventricular dysfunction . Circa scion 1984%9 :451-60.